Imaginostics

Develops a next-generation medical imaging technology based on QUTE-CE MRI, providing high-resolution vascular biomarkers. This non-invasive approach enables precise assessment of the structure and function of small blood vessels throughout the body, offering clinicians and researchers new tools for the early detection and characterization of complex diseases, including cancer.